You have 9 free searches left this month | to do more
Showing 1 - 25 of
124 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
Z
Not yet recruiting
  • High-Risk and Oligometastatic Prostate Cancer
  • Apalutamide
  • (no location specified)
2021-08-02
Aug 2, 2021
R
Not yet recruiting
  • Small Cell Neuroendocrine Carcinoma
  • +2 more
  • Apalutamide
  • Cetrelimab
  • San Francisco, California
    University of California, San Francisco
2022-01-11
Jan 11, 2022
U
Terminated
  • Prostate Adenocarcinoma
  • Apalutamide
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-12-28
Dec 28, 2021
C
Recruiting
  • Prostate Cancer
  • Shatin, Hong Kong
    Prince of Wales Hospital
2021-08-03
Aug 3, 2021
W
Active, not recruiting
  • Prostate Cancer Metastatic
  • Apalutamide
  • +3 more
  • Omaha, Nebraska
  • +1 more
2021-08-26
Aug 26, 2021
J
Active, not recruiting
  • Prostatic Neoplasms
  • Apalutamide
  • Beijing, China
  • +3 more
2021-12-02
Dec 2, 2021
J
Recruiting
  • Hepatic Impairment
  • Apalutamide
  • Orlando, Florida
  • +2 more
2021-12-02
Dec 2, 2021
I
Active, not recruiting
  • Prostate Cancer
  • Sao Paulo, SP, Brazil
    Instituto do Cancer do Estado de Sao Paulo
2021-05-14
May 14, 2021
U
Withdrawn
  • Prostatic Neoplasms, Castration-Resistant
  • (no location specified)
2020-11-15
Nov 15, 2020
C
Completed
  • Prostate Cancer
  • Leuprolide acetate
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
2021-03-24
Mar 24, 2021
K
Recruiting
  • Metastatic Castration-sensitive Prostate Cancer
  • Apalutamide
  • Ōsaka-sayama, Osaka, Japan
    Kindai University Hospital
2020-12-06
Dec 6, 2020
U
Recruiting
  • Castration Levels of Testosterone
  • +3 more
  • Apalutamide
  • Stereotactic Body Radiation Therapy
  • San Francisco, California
    University of California, San Francisco
2021-08-26
Aug 26, 2021
W
Recruiting
  • Prostatic Neoplasms
  • Standard of care
  • Apalutamide 60Mg Tab
  • Münster, North Rhine-Westfalia, Germany
    University Hospital Münster
2021-01-04
Jan 4, 2021
U
Recruiting
  • Prostate Cancer
  • +3 more
  • Leuven, Vlaams-brabant, Belgium
    University Hospitals Leuven
2020-12-23
Dec 23, 2020
D
Active, not recruiting
  • Prostate Cancer
  • Apalutamide
  • +3 more
  • La Jolla, California
  • +3 more
2021-09-01
Sep 1, 2021
J
Active, not recruiting
  • Salivary Gland Neoplasms
  • Apalutamide
  • GnRH Agonist
  • Chuo-Ku, Japan
  • +6 more
2021-12-02
Dec 2, 2021
M
Completed
  • Prostate Adenocarcinoma
  • +4 more
  • Abiraterone Acetate
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-05-14
May 14, 2021
E
Withdrawn
  • Prostate Cancer
  • Radiation Therapy
  • +3 more
  • (no location specified)
2020-08-13
Aug 13, 2020
C
Recruiting
  • Cancer of Prostate
  • Apalutamide
  • +4 more
  • Aalst, Belgium
  • +8 more
2021-08-04
Aug 4, 2021
J
Completed
  • Healthy
  • Apalutamide
  • Merksem, Belgium
    Clinical Pharmacology Unit
2020-08-07
Aug 7, 2020
N
Recruiting
  • Localized Prostate Carcinoma
  • +8 more
  • Apalutamide
  • Quality-of-Life Assessment
  • Tucson, Arizona
  • +4 more
2021-12-11
Dec 11, 2021
K
Recruiting
  • Castration-Resistant Prostate Cancer
  • Enzalutamide or Abiraterone or Apalutamid
  • Port Jefferson Station, New York
    North Shore Hematology Oncology Associates
2021-02-17
Feb 17, 2021